Search Count: 44
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Compound 2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.23 Å Release Date: 2025-05-14 Classification: CELL CYCLE Ligands: EDO, A1I76, K |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Compound 4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-05-14 Classification: CELL CYCLE Ligands: EDO, A1I8D |
 |
Crystal Structure Of S/T Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Inhibitor L2W
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2022-06-22 Classification: TRANSFERASE Ligands: FE, 8ZC, NA |
 |
Crystal Structure Of Smyd3 With Diperodon S Enantiomer Bound To Allosteric Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2021-03-03 Classification: ONCOPROTEIN Ligands: SAM, QKT, ZN, ACT, GOL |
 |
Crystal Structure Of Smyd3 With Diperodon R Enantiomer Bound To Allosteric Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2021-01-13 Classification: ONCOPROTEIN Ligands: SAM, GOL, POW, ZN |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Compound F1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.08 Å Release Date: 2020-07-29 Classification: CELL CYCLE Ligands: QGN, EDO |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Compound F5
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2020-07-29 Classification: CELL CYCLE Ligands: EDO, QGQ |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With Compound Ssr4
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2020-07-29 Classification: CELL CYCLE Ligands: EDO, QHE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2016-11-23 Classification: CHAPERONE Ligands: IEE, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-11-23 Classification: CHAPERONE Ligands: IQ5, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2016-11-23 Classification: CHAPERONE Ligands: SO4, TQL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: MG, ZZ2 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: DMS, ZZ3 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: MG, ZZ3 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: ZZ4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: ZZ5 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: ZZ6 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2009-07-28 Classification: CHAPERONE Ligands: 2KL |
 |
4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2007-12-11 Classification: CHAPERONE Ligands: 2GJ |
 |
4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2007-12-11 Classification: CHAPERONE Ligands: 2EQ |